Drug Testing Equipment Market Trends

  • Report ID: 3821
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Drug Testing Equipment Market - Growth Drivers and Challenges

Growth Drivers

  • Stringent Regulations of Sports Association – The adoption of several programs that are designed to detect the use of banned substances and strict drug testing for illegal drug abuse by athletes worldwide during the sports session is anticipated to propel the market growth. Sports organizations such as the International Olympic Committee (IOC), the International Sports Federation (ISF), and others have made drug testing mandatory for participants before participating in a sporting event.

  • Collaborations & Innovations in Testing Technology – The tangible benefits of collaborations include reduced medical errors, medication errors, and redundant tests, as well as innovative brainstorming, faster patient throughput, and improved provider satisfaction that come with a democratized and collegial care process. Intoximeters, Inc. with Abbott Healthcare Private Limited agreed to market SoToxa Mobile Test System of Abbott together with Alco-Sensor brand breath alcohol-testing products of Intoximeters.  SoToxa is a handheld oral fluid testing solution that will be used to detect drug use.

  • Emerging Laws – As per the Biden-Harris Administration’s Unity Agenda, around USD 3.8 billion has been invested through the American Rescue Plan by the administration to address the mental health crisis and drug overdose plague in the United States.

Challenges

  • Emerging Policies & Ban on Testing of Drugs - Drug testing in some places (particularly the workplace) is regarded as a violation of employee privacy, which is expected to impede market growth. The drug consumption ban in certain areas, as well as accuracy issues, are expected to pose challenges to the drug screening market.

  • Lack of Accuracy in Many Cases

  • Slower Penetration Due to Privacy Concerns


Base Year

2025

Forecast Year

2026-2035

CAGR

11.2%

Base Year Market Size (2025)

USD 8.82 billion

Forecast Year Market Size (2035)

USD 25.5 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of drug testing equipment is evaluated at USD 9.71 billion.

The global drug testing equipment market size was worth over USD 8.82 billion in 2025 and is poised to grow at a CAGR of around 11.2%, reaching USD 25.5 billion revenue by 2035.

The North America drug testing equipment market is forecast to secure nearly 40% share by 2035, reinforced by the strong presence of industry players promoting drug screening and the heightened concern over escalating drug abuse in the region.

Key players in the market include Sandoz International GmbH, Quest Diagnostics Incorporated, Butterfly Network, Inc., F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Cordant Health Solutions, Legacy Medical Services, LLC, Omega Laboratories, Inc., GE Healthcare.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos